EVENITY® (Romosozumab) is a biologic indicated for treatment of postmenopausal women at high risk for fracture or patients who have failed or are intolerant to other available osteoporosis therapy.
EVENITY® is manufactured by Amgen.
Administration and Dosage:
Administration of EVENITY® is 2 subcutaneous injections once a month for 12 months.
Common Side Effects:
The more common side effects of EVENITY® include serious allergic reactions, low calcium levels in your blood (hypocalcemia), severe jaw bone problems (osteonecrosis), unusual thigh bone fractures, joint pains, and headaches.
Ready to Schedule an Appointment?
Please CLICK HERE to get started.
EVENITY® is indicated to treat: